Time: 2021-08-18
Views: 699
The latest global market forecast report for smoking cessation aids released by ResearchAndMarkets, a research institution, shows that by 2028, this market will reach 64 billion U.S. dollars.
According to this report, the market is expected to grow from US$23.413 billion in 2021 to US$64.03 billion in 2028, and the market growth rate is expected to be 15.5%. The key factors driving the growth of this market are the increase in smoking addiction and the increase in the number of activities to reduce smoking and tobacco dependence. However, the high cost of nicotine replacement therapy development may inhibit market growth in the next few years to a certain extent.
According to end users, the smoking cessation assistance market is segmented into hospital pharmacies, online channels, retail pharmacies, and other end users. The retail pharmacy sector may occupy the largest market share in 2021, but the online channel sector is expected to have the highest market compound annual growth rate during the forecast period.
As participants in the smoking cessation aid market introduce new and innovative therapies, the substance and tobacco abuse treatment industry competes every year. For example, in July 2020, Dr Reddy's Laboratories announced the launch of over-the-counter nicotine Polacrilex lozenges in the US market. The company launched 2 mg and 4 mg nicotine Polacrilex lozenges in the United States.
In addition, top players in the market are also working with third parties to improve their existing smoking cessation aid product line. For example, in March 2016, GlaxoSmithKline partnered with digital cessation company 2Morrow to provide GSK's Nicoderm CQ Patch to smokers who completed the 2morrow smoking cessation plan.
In addition, market participants at the local and regional levels are launching nicotine-free e-cigarettes and medical devices such as e-cigarettes. Therefore, in the next few years, the continuous introduction of new and innovative smoking cessation aids will become a popular trend in the smoking cessation aid market.